Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factorAnaïs Schavgoulidze, Jill Corre, Xavier Leleu et al.|Blood|2022Cited by 64
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical featuresTitouan Cazaubiel, Jill Corre, Xavier Leleu et al.|Blood|2022Cited by 30